There could also be an interaction between estrogen deficiency and RA-genetic risk alleles promoting enhanced Th17-cell autoreactivity, manifested by ACPA (+) RA that exacerbates the inflammatory conditions and enhances loss. Here, PRTN3 is linked to rheumatoid arthritis.